STIM 0.95 Stock Price Neuronetics, Inc.
Range: | 0.52-5.07 | Vol Avg: | 446985 | Last Div: | 0 | Changes: | 0.05 |
Beta: | 2.22 | Cap: | 0.03B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Thu Jun 28 2018 | Empoloyees: | 203 |
CUSIP: | 64131A105 | CIK: | 0001227636 | ISIN: | US64131A1051 | Country: | US |
CEO: | Mr. Keith J. Sullivan | Website: | https://www.neurostar.com |
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.